Hubei Biocause Heilen Pharmaceutical Co., Ltd. proposed final cash dividend of CNY 4.00000000 per 10 shares (tax included) for the year 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.61 CNY | -0.27% |
|
-4.45% | -32.83% |
1st Jan change | Capi. | |
---|---|---|
-32.83% | 579M | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B |
- Stock Market
- Equities
- 301211 Stock
- News Hubei Biocause Heilen Pharmaceutical Co., Ltd.
- Hubei Biocause Heilen Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2022